login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
All US stocks
All Canadian stocks
All European stocks
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Account
Disclaimer
Affiliate
Contact
Privacy
ARCUTIS BIOTHERAPEUTICS INC (ARQT) Stock News
NASDAQ:ARQT - Nasdaq -
US03969K1088
-
Common Stock
- Currency: USD
14.835
-0.18 (-1.23%)
Summary
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
ARQT Latest News, Press Relases and Analysis
All
Press Releases
6 hours ago - By: Benzinga
- Mentions:
CHE
AAOI
TDOC
PLTR
This Palantir Technologies Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday
2 days ago - By: Arcutis Biotherapeutics, Inc.
Arcutis to Report Second Quarter 2025 Financial Results and Host Conference Call on August 6, 2025
22 days ago - By: Arcutis Biotherapeutics, Inc.
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
a month ago - By: Arcutis Biotherapeutics, Inc.
Arcutis’ ZORYVE® (roflumilast) Cream 0.15% Receives Strong Recommendation in American Academy of Dermatology Updated Guidelines for Adult Atopic Dermatitis
2 months ago - By: Benzinga
Analyst Expectations For Arcutis Biotherapeutics's Future
a month ago - By: Yahoo Finance
- Mentions:
VZ
AMZN
WMT
CADE
...
How Cadence Bank, Kimberly-Clark, And Robert Half Can Put Cash In Your Pocket
a month ago - By: Yahoo Finance
- Mentions:
UBS
KR
UNP
DE
...
UBS Maintains Neutral on Kroger Ahead of Earnings, Sees Balanced Risk-Reward Outlook
a month ago - By: Yahoo Finance
- Mentions:
BLND
SNY
NVDA
TSM
...
Covius Services to Acquire Blend Labs’ (BLND) Title365 Holding Co
a month ago - By: Yahoo Finance
- Mentions:
ELV
ACGL
AGIO
AZN
...
Truist Lowers Elevance Health (ELV) to $500, Keeps Buy Rating
a month ago - By: Yahoo Finance
- Mentions:
SPRY
MEOH
GSC
KR
...
Jim Cramer on ARS Pharmaceuticals: “It’s a Great Flier”
2 months ago - By: Arcutis Biotherapeutics, Inc.
Arcutis Enrolls First Child in INTEGUMENT-INFANT Evaluating ZORYVE® (roflumilast) Cream 0.05% in Infants with Atopic Dermatitis
2 months ago - By: Arcutis Biotherapeutics, Inc.
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2 months ago - By: Arcutis Biotherapeutics, Inc.
Arcutis to Present New Long-Term Results of ZORYVE® (roflumilast) Cream at the 2025 Revolutionizing Atopic Dermatitis Conference
2 months ago - By: Arcutis Biotherapeutics, Inc.
Arcutis to Present New Long-Term Results of ZORYVE® (roflumilast) Cream at the 2025 Revolutionizing Atopic Dermatitis Conference
2 months ago - By: Arcutis Biotherapeutics, Inc.
Arcutis to Present at the Goldman Sachs 46th Annual Global Healthcare Conference
2 months ago - By: Arcutis Biotherapeutics, Inc.
Arcutis’ ZORYVE® (roflumilast) Topical Foam 0.3% Approved by U.S. FDA for the Treatment of Plaque Psoriasis in Adults and Adolescents Ages 12 and Older
2 months ago - By: Arcutis Biotherapeutics, Inc.
Arcutis’ ZORYVE® (roflumilast) Topical Foam 0.3% Approved by U.S. FDA for the Treatment of Plaque Psoriasis in Adults and Adolescents Ages 12 and Older
2 months ago - By: Arcutis Biotherapeutics, Inc.
New Consensus Statements on Impact of Genital Psoriasis on Patients from Genital Psoriasis Wellness Consortium Published in Journal of the European Academy of Dermatology and Venereology Clinical Practice
2 months ago - By: Arcutis Biotherapeutics, Inc.
New Consensus Statements on Impact of Genital Psoriasis on Patients from Genital Psoriasis Wellness Consortium Published in Journal of the European Academy of Dermatology and Venereology Clinical Practice
3 months ago - By: Arcutis Biotherapeutics, Inc.
Arcutis Announces Publication of Positive Data from ARRECTOR Trial Evaluating ZORYVE® (roflumilast) Foam 0.3% in Individuals with Psoriasis in Journal of American Medical Association Dermatology
3 months ago - By: Arcutis Biotherapeutics, Inc.
Arcutis Announces Publication of Positive Data from ARRECTOR Trial Evaluating ZORYVE® (roflumilast) Foam 0.3% in Individuals with Psoriasis in Journal of American Medical Association Dermatology
3 months ago - By: Zacks Investment Research
- Mentions:
SABS
Arcutis Biotherapeutics, Inc. (ARQT) Reports Q1 Loss, Tops Revenue Estimates
3 months ago - By: Arcutis Biotherapeutics, Inc.
Arcutis Announces First Quarter 2025 Financial Results and Provides Business Update
3 months ago - By: Arcutis Biotherapeutics, Inc.
Arcutis Announces First Quarter 2025 Financial Results and Provides Business Update
3 months ago - By: Arcutis Biotherapeutics, Inc.
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
3 months ago - By: Zacks Investment Research
- Mentions:
QGEN
Qiagen (QGEN) Reports Next Week: Wall Street Expects Earnings Growth
3 months ago - By: Zacks Investment Research
- Mentions:
ALKS
Arcutis Biotherapeutics, Inc. (ARQT) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
3 months ago - By: Zacks Investment Research
Is Arcutis Biotherapeutics (ARQT) Stock Outpacing Its Medical Peers This Year?
4 months ago - By: Arcutis Biotherapeutics, Inc.
Arcutis Announces Chief Financial Officer Transition
4 months ago - By: Arcutis Biotherapeutics, Inc.
Arcutis Announces Chief Financial Officer Transition
4 months ago - By: Yahoo Finance
- Mentions:
UWMC
RKT
HD
COOP
Why UWM Holdings Corp. (UWMC) Went Up On Wednesday?
4 months ago - By: Yahoo Finance
Why Arcutis Biotherapeutics Inc. (ARQT) Went Up On Wednesday?
4 months ago - By: Arcutis Biotherapeutics, Inc.
Arcutis and Padagis Agree to Stay Patent Lawsuit
4 months ago - By: Arcutis Biotherapeutics, Inc.
Arcutis and Padagis Agree to Stay Patent Lawsuit
Please enable JavaScript to continue using this application.